Investment by Guangzhou Sino-Israel Bio-Industry Investment Fund (LLP)Equity Joint Venture Agreement • October 11th, 2018 • InMode Ltd. • Electromedical & electrotherapeutic apparatus
Animated by the purpose of facilitating the cooperation in the investment in the Bio-industry by the parties to this contract, in accordance with the “Law of the People’s Republic of China on Chinese-Foreign Equity Joint Ventures”, its detailed rules and other relevant laws and regulations of China, based on the principle of equality and mutual benefits, through friendly and candid consultation, all parties agree to jointly form, effective as of Closing, a Chinese Equity Joint Venture company in the Guangzhou Development District (the “GDD”)/Bio-Island which will be engaged in the territory of the mainland of People’s Republic of China, Hong Kong, Taiwan and Macau, in the (i) importation, distribution, marketing and sale of devices and certain products manufactured by Party B, and (ii) development, performance of clinical trials, design and manufacturing of devices and products, distribution, marketing and sale, support and provision of warranty based on Party B’s technology. In this r
InMode letterhead]Consent to Waive Equity Swap Provision of Mou • October 11th, 2018 • InMode Ltd. • Electromedical & electrotherapeutic apparatus
Reference is made to the Founders Memorandum of Understanding, dated as of March 4, 2014 (the “MOU”), by and between InMode Ltd. (formerly Invasix Ltd.) (“Inmode”) and Wigmore Medical Limited (“Wigmore”). As of the date of this letter, Wigmore holds 49% of the outstanding share capital of Invasix UK Ltd., a subsidiary of InMode (“Invasix UK”). Capitalized terms used herein and not otherwise defined herein shall have the meanings assigned to such terms in the MOU.
InMode letterhead]Consent to Waive Equity Swap Provision • October 11th, 2018 • InMode Ltd. • Electromedical & electrotherapeutic apparatus
Reference is made to the agreement dated as of September 9th, 2016 (the “Agreement), by and between InMode Ltd. (formerly Invasix Ltd.) (“Inmode”) and Guangzhou Sino-Israel Bio-Industry Investment Fund (“GIBF”). As of the date of this letter, GIBF holds 49% of the outstanding share capital of Guangzhou InMode Medical Technology Ltd., a subsidiary of InMode Ltd.
